Increased projection of MHC and tumor antigens in murine B16-BL6 melanoma induced by hydrostatic pressure and chemical crosslinking
- PMID: 8477415
- PMCID: PMC11038729
- DOI: 10.1007/BF01741167
Increased projection of MHC and tumor antigens in murine B16-BL6 melanoma induced by hydrostatic pressure and chemical crosslinking
Abstract
The B16-BL6 melanoma, like most spontaneously arising tumors, is poorly immunogenic and expresses low levels of major histocompatibility complex (MHC) antigens. Treatment of cells of this tumor in vitro by hydrostatic pressure in the presence of adenosine 2',3'-dialdehyde (oxAdo), a membrane-impermeant crosslinker, caused elevated projection of MHC and a specific tumor antigen as demonstrated by flow-cytometric analysis. Maximum projection of both the MHC and the tumor antigens could be reached by application of 1200 atm for 15 min in the presence of 20 mM oxAdo. It is not yet clear whether this passive increase in availability of antigens on the cell surface originated from a dormant pool of antigens in the plasma membrane or from pressure-induced fusion of antigen-rich intracellular organelles (e.g. the endoplasmic reticulum). The immunogenic properties of the antigen-enriched B16-BL6 cells are described in the following paper.
Similar articles
-
Induction of cell-mediated immunity against B16-BL6 melanoma in mice vaccinated with cells modified by hydrostatic pressure and chemical crosslinking.Cancer Immunol Immunother. 1993 May;36(5):300-6. doi: 10.1007/BF01741168. Cancer Immunol Immunother. 1993. PMID: 8477416 Free PMC article.
-
Surface projection of murine major histocompatibility determinants induced by hydrostatic pressure and cytokines.Pathobiology. 1996;64(3):142-9. doi: 10.1159/000164028. Pathobiology. 1996. PMID: 8910923
-
MHC antigen expression by melanomas recovered from mice treated with allogeneic mouse fibroblasts genetically modified for interleukin-2 secretion and the expression of melanoma-associated antigens.Cancer Immunol Immunother. 1994 Mar;38(3):185-93. doi: 10.1007/BF01525640. Cancer Immunol Immunother. 1994. PMID: 8124687 Free PMC article.
-
Pulsing of dendritic cells with cell lysates from either B16 melanoma or MCA-106 fibrosarcoma yields equally effective vaccines against B16 tumors in mice.J Surg Oncol. 1998 Jun;68(2):79-91. doi: 10.1002/(sici)1096-9098(199806)68:2<79::aid-jso3>3.0.co;2-h. J Surg Oncol. 1998. PMID: 9624036 Review.
-
MHC class I genes controlling the metastatic phenotype of tumor cells.Semin Cancer Biol. 1991 Oct;2(5):337-46. Semin Cancer Biol. 1991. PMID: 1773049 Review.
Cited by
-
Induction of cell-mediated immunity against B16-BL6 melanoma in mice vaccinated with cells modified by hydrostatic pressure and chemical crosslinking.Cancer Immunol Immunother. 1993 May;36(5):300-6. doi: 10.1007/BF01741168. Cancer Immunol Immunother. 1993. PMID: 8477416 Free PMC article.
References
-
- Ashley M, Kotlarski I. In vivo cytotoxic responses induced by allogeneic normal and neoplastic cells in mice: relative lack of immunogenicity of B16 melanoma cells. Cell Immunol. 1986;1:157–157. - PubMed
-
- De Baestalier P, Katzav S, Gorelik E, Feldman M, Segal S. Differential expression of H-2 gene products in tumor cells is associated with their metastatogenic properties. Nature. 1980;288:179–179. - PubMed
-
- Doherty P, Knowles B, Wettstein PI. Immunological surveillance of tumors in the context of major histocompatibility complex restriction of T-cell function. Adv Cancer Res. 1984;42:1–1. - PubMed
-
- Eisenthal A, Shiloni E, Rosenberg SA. Characterization of IL-2 induced murine cells which exhibit ADCC activity. Cell Immunol. 1988;115:257–257. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous